Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative phosphorylation pathway proteins are a group of enzymes and associated molecules that form the mitochondrial electron transport chain. These proteins are responsible for transferring electrons from NADH and FADH₂ to molecular oxygen through a series of redox reactions across four main multi-subunit complexes (Complexes I-IV) embedded in the inner mitochondrial membrane. This process generates a proton gradient used by ATP synthase (Complex V) to produce adenosine triphosphate (ATP), the primary energy currency in cells. The pathway is essential for aerobic metabolism in eukaryotes and is also present with variations in prokaryotes. Dysfunction or altered regulation of these proteins is implicated in various diseases, including cancer—where they may serve as therapeutic targets—and neurodegenerative disorders due to their role in energy metabolism and reactive oxygen species generation[1][2][4][8]. Note on correctness: The term "Oxidative phosphorylation pathway proteins" refers collectively to many different individual proteins rather than a single molecular target or receptor. For structured data purposes, it would be more accurate to specify an individual component such as "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9" or "Cytochrome c oxidase subunit 4 isoform 1." As written, this entry describes a functional class rather than one canonical molecule; thus **is_incorrect** is set to true because it does not refer specifically enough for most drug discovery databases or structured target lists[1].
Inhibition of electron transport chain complexes to disrupt ATP production and induce cell death in target cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative phosphorylation pathway protein (OXPHOS protein).